NAEVR Commends the Senate for Passing S 5, the Stem Cell Research Enhancement Act

April 11, 2007
CONTACT: James F. Jorkasky
Executive Director
[email protected]


S 5 The Stem Cell Research Enhancement Act

(Washington, D.C.) Today, the National Alliance for Eye and Vision Research (NAEVR) commended the United States Senate for passing S 5, the Stem Cell Research Enhancement Act, by a vote of 63-34. The House of Representatives passed its companion bill, HR 3, back in January. Due to minor differences in the text of the two bills, they must now be reconciled, either through a conference committee or by the House voting on the Senate’s version of the bill, before it can be sent to the President.

“The Senate’s action, along with the House vote earlier this year, demonstrates the broad support that this promising field of medical research has in Congress” stated NAEVR Executive Director James Jorkasky. “We are proud that members of the vision research community have emailed thousands of letters to House and Senate offices in support of HR 3/S 5.”

NAEVR has supported expanded embryonic stem cell research due to the promise it holds for the more than 100 million Americans suffering from debilitating diseases and disorders, such as cancer, Alzheimer’s, spinal cord injuries and diabetes, which results in sight-impairing diabetic retinopathy. Embryonic stem cell research also holds the promise of treatments for other eye diseases, such as macular degeneration, glaucoma and retinitis pigmentosa.

The National Alliance for Eye and Vision Research (NAEVR) is a non-profit advocacy coalition comprised of 55 professional, consumer and industry organizations involved in eye and vision research. NAEVR’s goal is to achieve the best vision for all Americans through advocacy and public education for eye and vision research sponsored by the National Institutes of Health (NIH), the National Eye Institute (NEI) and other federal research entities. Visit NAEVR’s Web site at